Wall Street analysts follow S&P 500 stocks more closely than almost anyone. But even they get it wrong sometimes, too.
LabCorp announced that it is pursuing a tax-free spinoff of its Drug Development segment. The transaction will separate a slower-growing, highly profitable cash cow from a high growth business, allowi

What 4 Analyst Ratings Have To Say About Laboratory Corp

02:14pm, Monday, 22'nd Aug 2022 Benzinga
Within the last quarter, Laboratory Corp (NYSE:LH) has observed the following analyst ratings:   Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 3 0 0 0 Last 30

BD's (BDX) Latest Collaboration to Boost Patient Outcome

01:28pm, Thursday, 18'th Aug 2022 Zacks Investment Research
BD's (BDX) tie-up with Accelerate Diagnostics is expected to strengthen the fight to combat the global threat of antimicrobial resistance, thereby boosting patient care.

Laboratory Corp: The Force Is Strong With This One

08:15am, Wednesday, 17'th Aug 2022
Labcorp is a well-run company that should benefit from long-term secular trends in the healthcare industry. It benefits from its large patient database, which aids its drug development services busine

BD (BDX) Ties Up With LabCorp to Boost Patient Outcome

02:00pm, Monday, 15'th Aug 2022 Zacks Investment Research
BD's (BDX) latest partnership is expected to provide life-changing treatments for cancer and other diseases, thereby improving patient care.
Professional money managers have a strong preference for one stock sector in particular, along with cash dividends.
The S&P 500 Index has rallied 10% since June 22 from a deep decline, but there are different schools of thought about whether investors are out of the woods yet.

These 3 Companies Are Taking on Monkeypox

02:37pm, Thursday, 04'th Aug 2022 The Motley Fool
A vaccine maker, a therapeutics company, and a medical lab could suit a variety of investor risk profiles.

These 3 Companies Are Taking on Monkeypox

10:37am, Thursday, 04'th Aug 2022
A vaccine maker, a therapeutics company, and a medical lab could suit a variety of investor risk profiles.
LH, $257.94; Market Capitalization: $23.3 billion), a leading global life sciences company, announced that its Board of Directors authorized a plan to spin-off Clinical Development business into an in
Keybanc cut the price target on Airbnb, Inc. (NASDAQ: ABNB) from $195 to $145. However, Keybanc analyst Justin Patterson maintained the stock with an Overweight. Airbnb shares rose 0.7% to $111.70 i

Time for a Breath of Sanity

10:47am, Monday, 01'st Aug 2022
After a drop of about 20% in the first six months of this year, investors feel nervous even though July has been good.

Where Laboratory Corp Stands With Analysts

06:07pm, Friday, 29'th Jul 2022 Benzinga
Over the past 3 months, 4 analysts have published their opinion on Laboratory Corp (NYSE:LH) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a com
LH earnings call for the period ending June 30, 2022.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE